Description
A triple GIP/GLP-1/glucagon receptor agonist at the forefront of metabolic research. Studied benefits include:
- Significant reduction in body fat
- Improved appetite regulation and satiety
- Enhanced metabolic markers (glucose and lipid levels)
- Optimization of body composition
